SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-059096
Filing Date
2010-12-08
Accepted
2010-12-08 15:31:52
Documents
2
Period of Report
2010-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
2 EX-24 DOCUMENT attachment1.htm EX-24 3952
  Complete submission text file 0001209191-10-059096.txt   7282
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address
Liang Bertrand C. (Reporting) CIK: 0001507123 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 101239815